Goldman Sachs Group Inc
OpenAI gets $4 billion revolving credit line, giving it more than $10 billion in liquidity
OpenAI has a $4 billion revolving line of credit, bringing its total liquidity to more than $10 billion, CNBC has learned. It follows news on Wednesday that OpenAI closed its recent funding round at a valuation of $157 billion, including the $6.6 billion the company raised from an extensive roster of investment firms and big […]
Read More
Klarna CEO says a European tech brain drain is ‘number one risk’ for company ahead of IPO
Key Points Klarna CEO Sebastian Siemiatkowski told CNBC that unfavorable share-based compensation rules in Europe could lead to Klarna losing talent to tech giants in the U.S. such as Google, Apple and Meta. In a wide-ranging interview, he said that the lack of attractiveness of Europe for tech talent is the “number one risk” facing the […]
Read More
CNBC Daily Open: Buffeted by Middle East, propelled by China
Customers at a restaurants on Nanjing East Road in Shanghai, China, on Wednesday, Oct. 2, 2024. Qilai Shen | Bloomberg | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like […]
Read More
Supply chain disruptions could benefit these stocks, Goldman Sachs says
Global supply chains and trade have been facing no shortage of challenges in the past few years. Factors ranging from Covid-19 pandemic disruptions to Red Sea tensions have driven freight rates up and affected deliveries. Trade tensions, too, have resulted in tariffs and affected world trade in certain goods. Just this week, strikes at the […]
Read More
Meet the ex-Goldman wealth advisor who quit to solve Britain’s £567 billion gender investment gap
Ayesha Ofori, founder and CEO of Propelle. Propelle Ayesha Ofori is a former Goldman Sachs wealth advisor who quit her high-profile job to resolve Britain’s gender wealth gap, after realizing she had spent her career making rich men even richer. Ofori is the 40-year-old founder and CEO of female-focused financial investment platform, Propelle, which launched […]
Read More
CNBC Daily Open: It might be better economic data isn’t all rosy
People shop at a home improvement store on August 14, 2024, in New York City. Spencer Platt | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Like what you see? […]
Read More
Goldman names its top global battery stocks — giving 2 over 50% upside
Battery prices have been sliding, but Goldman Sachs continues to see promise in the sector, naming four market-leading stocks it’s overweight on. The investment bank’s analysts said global average battery prices could fall to around $80/kilowatt hour by 2026 compared to $110/kilowatt hour this year, in a Sept. 4 equity research note. At this level, […]
Read More
Fed’s jumbo interest rate cut puts the U.S. on track for a soft landing, Goldman CFO says
U.S. Federal Reserve Chair Jerome Powell holds a press conference in Washington, D.C., on Sept. 18, 2024. Mandel Ngan | AFP | Getty Images The Federal Reserve’s move to lower interest rates by 50 basis points puts the U.S. economy on track for a soft landing, according to Goldman Sachs‘ chief financial officer. His comments […]
Read More
With rates falling, don’t make this ‘big mistake’ with your cash
If you haven’t started moving out of cash, you may not want to wait much longer. Yields are coming down now that the Federal Reserve has started its rate-cutting cycle , decreasing the federal funds rate by half a percentage point on Wednesday. Still, there is a near record $6.3 trillion sitting in money market […]
Read More
Biotech stocks are an unappreciated way to profit from lower rates, Goldman says
As investors await the Federal Reserve rate decision Wednesday afternoon, Goldman Sachs highlighted to clients an overlooked group of stocks poised to benefit from the move. Biotechnology stocks offer an under-the-radar and unappreciated way to profit from the central bank’s looming campaign to start cutting the cost of borrowing, according to Goldman Sachs. “For those […]
Read More